Emma Prescott
Overview
Explore the profile of Emma Prescott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chevalier J, Yin H, Arpino J, ONeil C, Nong Z, Gilmore K, et al.
iScience
. 2020 Jul;
23(6):101251.
PMID: 32629616
Critical limb ischemia (CLI) is a hazardous manifestation of atherosclerosis and treatment failure is common. Abnormalities in the arterioles might underlie this failure but the cellular pathobiology of microvessels in...
2.
Zonoozi S, Barnard M, Prescott E, Jones R, Shah F, Tzoulis P
Mediterr J Hematol Infect Dis
. 2017 Jan;
9(1):e2017004.
PMID: 28101310
Sitagliptin, a modern antidiabetic agent which is weight neutral and associated with low rate of hypoglycaemias, is being increasingly used in type 2 diabetes mellitus (DM). However, there is a...
3.
Tzoulis P, Ang A, Shah F, Berovic M, Prescott E, Jones R, et al.
Hemoglobin
. 2014 Apr;
38(3):173-8.
PMID: 24762040
Low bone mass, a major cause of morbidity in patients with β-thalassemia major (β-TM), is multifactorial. There is lack of data about the current prevalence of low bone mass in...
4.
Tzoulis P, Shah F, Jones R, Prescott E, Barnard M
Hemoglobin
. 2013 Dec;
38(2):104-10.
PMID: 24351096
Diabetes is a significant complication of β-thalassemia major (β-TM) and most patients receive fragmented diabetes care. In 2005, we developed a unique Joint Diabetes Thalassaemia Clinic, based at the Department...
5.
Ang A, Tzoulis P, Prescott E, Davis B, Barnard M, Shah F
Eur J Haematol
. 2013 Oct;
92(3):229-36.
PMID: 24164584
Endocrinopathies are common complications of transfusional hemosiderosis among patients with β thalassemia major (TM). Previous studies had shown associations between some endocrinopathies and iron overload of the myocardium, liver and/or...
6.
Westwood M, Anderson L, Maceira A, Shah F, Prescott E, Porter J, et al.
J Magn Reson Imaging
. 2007 May;
25(6):1147-51.
PMID: 17520718
Purpose: To determine the reference range in thalassemia major (TM) for left ventricular (LV) function. Materials And Methods: We used cardiovascular magnetic resonance (CMR) to measure heart volumes and function...
7.
Anderson L, Westwood M, Prescott E, Walker J, Pennell D, Wonke B
Acta Haematol
. 2006 Jan;
115(1-2):106-8.
PMID: 16424659
It is believed that myocardial iron deposition and the resultant cardiomyopathy only occur in the presence of severe liver iron overload. Using cardiovascular magnetic resonance, it is now possible to...
8.
Westwood M, Wonke B, Maceira A, Prescott E, Walker J, Porter J, et al.
J Magn Reson Imaging
. 2005 Jul;
22(2):229-33.
PMID: 16028255
Purpose: To compare left ventricular (LV) diastolic function with myocardial iron levels in beta thalassemia major (TM) patients, using cardiovascular magnetic resonance (CMR). Materials And Methods: We studied 67 regularly...
9.
Anderson L, Westwood M, Holden S, Davis B, Prescott E, Wonke B, et al.
Br J Haematol
. 2004 Oct;
127(3):348-55.
PMID: 15491298
Heart failure from iron overload causes 71% of deaths in thalassaemia major, yet reversal of siderotic cardiomyopathy has been reported. In order to determine the changes in myocardial iron during...
10.
Anderson L, Wonke B, Prescott E, Holden S, Walker J, Pennell D
Lancet
. 2002 Sep;
360(9332):516-20.
PMID: 12241655
Background: Despite the introduction of the parenteral iron chelator desferrioxamine more than 30 years ago, 50% of patients with thalassaemia major die before the age of 35 years, predominantly from...